Diagnosis Using Integrated Metabolomics And Genomics In Neurodevelopment (IMAGINE)

Brain injuries in early life are commonly thought to cause cerebral palsy in many children, but in some children the underlying cause is a metabolic or other genetic condition. Advances in genomics and metabolomics now allow us to diagnose these other causes of atypical cerebral palsy, and we believe that doing so will enable us to devise more personalized treatments that improve the outcomes for affected children.